276 related articles for article (PubMed ID: 11118389)
1. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
Fridkin SK
Clin Infect Dis; 2001 Jan; 32(1):108-15. PubMed ID: 11118389
[TBL] [Abstract][Full Text] [Related]
2. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC
Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
[TBL] [Abstract][Full Text] [Related]
4. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
[TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
McDonald LC; Hageman JC
Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
Fridkin SK; Hageman J; McDougal LK; Mohammed J; Jarvis WR; Perl TM; Tenover FC;
Clin Infect Dis; 2003 Feb; 36(4):429-39. PubMed ID: 12567300
[TBL] [Abstract][Full Text] [Related]
8. Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(35):813-5. PubMed ID: 9310213
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus resistant to vancomycin--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):565-7. PubMed ID: 12139181
[TBL] [Abstract][Full Text] [Related]
10. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
11. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
Burnie J; Matthews R; Jiman-Fatami A; Gottardello P; Hodgetts S; D'arcy S
Clin Infect Dis; 2000 Sep; 31(3):684-9. PubMed ID: 11017816
[TBL] [Abstract][Full Text] [Related]
13. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
Kosowska-Shick K; Ednie LM; McGhee P; Smith K; Todd CD; Wehler A; Appelbaum PC
Antimicrob Agents Chemother; 2008 Dec; 52(12):4510-3. PubMed ID: 18838583
[TBL] [Abstract][Full Text] [Related]
14. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
15. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
Borg MA; Zerafa R; Morrison D; Cuschieri P
Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
[TBL] [Abstract][Full Text] [Related]
16. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Appelbaum PC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
[TBL] [Abstract][Full Text] [Related]
17. [Searching for Staphylococcus aureus strains with reduced susceptibility to glycopeptides among clinical isolates obtained during the year of 2002].
Młynarczyk A; Młynarczyk G; Łuczak M
Med Dosw Mikrobiol; 2003; 55(3):209-17. PubMed ID: 14702662
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus with reduced susceptibility to vancomycin.
Cosgrove SE; Carroll KC; Perl TM
Clin Infect Dis; 2004 Aug; 39(4):539-45. PubMed ID: 15356818
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 48(51-52):1165-7. PubMed ID: 11266244
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore.
Sng LH; Koh TH; Wang GC; Hsu LY; Kapi M; Hiramatsu K
Int J Antimicrob Agents; 2005 Feb; 25(2):177-9. PubMed ID: 15664490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
